Rayence Co

Rayence Co Acquisitions (Net)

The Acquisitions (Net) of Rayence Co (228850.KQ) as of Oct 22, 2026 is 38.19 M KRW. In the previous year, Acquisitions (Net) was -16.59 B KRW — a change of -100.23% (higher).

Acquisitions (Net)

38.19 MKRW

YoY

-100.23%

Last updated:

Acquisitions (Net) of Rayence Co is 2024 38.19 M KRW. Acquisitions (Net) of Rayence Co was 2023 -16.59 B KRW. It decreases by -100.23% higher compared to the previous year.

The Rayence Co Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2017
6.86 B KRW
Jan 1, 2018
13.00 B KRW
Jan 1, 2019
-2.18 B KRW
Jan 1, 2020
3.42 B KRW
Jan 1, 2021
-18.09 B KRW
Jan 1, 2022
3.10 B KRW
Jan 1, 2023
-16.59 B KRW
Jan 1, 2024
38.19 M KRW
The Rayence Co Acquisitions (Net) history
YEARAcquisitions (Net)YoY
38.19 MKRW-100.23%
-16.59 BKRW-634.79%
3.10 BKRW-117.15%
-18.09 BKRW-629.01%
3.42 BKRW-257.10%
-2.18 BKRW-116.75%
13.00 BKRW+89.46%
6.86 BKRW-108.60%
-79.77 BKRW-2,423.71%
3.43 BKRW+803.42%
380.00 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rayence Co Stock analysis

What does Rayence Co do? Rayence Co., Ltd. generates revenue through the manufacturing and sale of x-ray detectors, including TFT and CMOS detectors under brand names such as 1012WCA, 17SCC/SGC, 1215CF, 1501CF, and 0712CF. The company also produces intra oral sensors branded as Ez1.0 and Ez1.5, along with mammography machines under the 1724CM and 2434CM series. These products are distributed to both domestic and international markets, serving healthcare providers and medical facilities that require diagnostic imaging equipment. The primary customers for Rayence's detectors and sensors are hospitals, clinics, and medical imaging centers seeking advanced x-ray technology. The firm's product portfolio targets the medical imaging segment, focusing on applications such as dental diagnostics with intra oral sensors and radiological imaging with mammography machines. Revenue streams are derived from direct sales of these branded products to healthcare institutions across multiple regions. Rayence's business model centers on selling specialized medical imaging equipment under its own brand names, with no mention of third-party partnerships or additional services. The company's revenue is directly tied to the purchase of its branded x-ray detectors, intra oral sensors, and mammography machines by healthcare providers who require high-quality diagnostic tools for patient care. Rayence Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rayence Co stock

Acquisitions (Net) of Rayence Co is 38.19 M KRW in 2024.

Acquisitions (Net) of Rayence Co changed from -16.59 B KRW to 38.19 M KRW, representing a -100.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Rayence Co since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Rayence Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Rayence Co

All Key Metrics — Rayence Co